Medrobotics has announced today that world’s first robotic-assisted scarfree colorectal surgery with the Medrobotics Flex Robotic System was performed at George Washington University Hospital. The procedure to remove a suspected cancerous lesion from the rectum of an adult male, was carried out by Dr Vincent Obias, Director of Robotics and Professor of Colorectal Surgery at the George Washington University Hospital. The Flex Robotic System is now the world’s first robotic surgical platform providing Scarfree access to hard-toreach anatomy in otolaryngology and colorectal procedures, providing surgeons treatment options that may not be possible with straight, rigid instruments, the company claims.
“The Flex Robotic System is the first robotic platform that allows surgeons to visualize and access lesions in the rectum and colon with a steerable and shapeable robotic scope and flexible instruments,” said Dr Obias. “This offers some patients the opportunity to be treated with fewer incisions and may result in reduced complications and faster recoveries.”
The Flex Robotic System, the world’s first robotic surgical platform with a steerable and shapeable robotic scope. The Flex Robotic System offers surgeons the unique ability to navigate complex anatomy through a single, small entry point while operating in hard-to-reach anatomical locations that might otherwise be inaccessible with straight, rigid surgical tools. The company’s vision is to provide more patients with access to Scarfree surgical options.
Today, access is gained through the mouth and anus. In future applications, access may be obtained through other natural orifices such as the vagina, or through small incisions in the abdomen. Medrobotics is developing new surgical applications for its core platform technology in the areas of general surgery, gynaecology, and urology, among others. These new applications are not yet cleared for use in the US.
“Until now, robotic-assisted colorectal surgery required multiple incisions through the abdomen because straight, rigid robotic tools were not designed to navigate the twists and turns of the human gastrointestinal system,” said Dr Samuel Straface, President and CEO of Medrobotics. “These procedures can result in complications, pain and scarring. The Flex Robotic System was designed to enable Scarfree robotic-assisted access to cancer and other lesions in the rectum and distal colon, following a path directly through the anus.”
Medrobotics received its initial FDA clearance for the Flex Robotic System in July 2015, and the CE Mark in March 2014.